Ambient

Molecular Formula : CH5AsO2

Molecular Formula : C17 H24 O4

Molecular Formula : C17 H24 O4

Molecular Formula : C17 D4 H20 O4

Molecular Formula : C16 H22 O4

Molecular Formula : C16 H22 O4

Molecular Formula : C22H30O10

Molecular Formula : C22H30O10

Molecular Formula : C16H18D4O4

Molecular Formula : C16H18D4O4

Molecular Formula : C18H24O5

Molecular Formula : C18H24O5

Monopalmitin

Molecular Formula : C13 H16 O4

Molecular Formula : C13 H16 O4

Molecular Formula : C13 H16 O4

Molecular Formula : C13 D4 H12 O4

Molecular Formula : C13 D4 H12 O4

Molecular Formula : C11H12O4

Molecular Formula : C11H12O4

Molecular Formula : C11 D4 H8 O4

Molecular Formula : C11 D4 H8 O4

Molecular Formula : C18H22D4O5

Molecular Formula : C18H22D4O5

GenScript MonoRab^TM Anti-DYKDDDDK Magnetic Beads are super paramagnetic beads with diameter of 70
μm, covalently coated with a rabbit monoclonal anti-DYKDDDDK antibody. The beads are supplied as 50%
slurry in TBS with 50% glycerol and 0.02% sodium azide. The MonoRab^TM Anti-DYKDDDDK Magnetic Beads
have a binding capacity of 1.5 mg DYKDDDDK-tagged protein (Size: 50KDa) per 1 ml settled beads. The beads
can be re-used for at least 5 times.
Based on our new rabbit monoclonal antibody technology (MonoRab^TM), this beads offers high binding
capacity, high purity, and withstand stringent washing steps, especially with buffers containing high
concentration of salt. The beads are resistant to up to 2 M NaCl, and to buffers with pH as low as 2.5.

GenScript MonoRab^TM Anti-DYKDDDDK Magnetic Beads are super paramagnetic beads with diameter of 70
μm, covalently coated with a rabbit monoclonal anti-DYKDDDDK antibody. The beads are supplied as 50%
slurry in TBS with 50% glycerol and 0.02% sodium azide. The MonoRab^TM Anti-DYKDDDDK Magnetic Beads
have a binding capacity of 1.5 mg DYKDDDDK-tagged protein (Size: 50KDa) per 1 ml settled beads. The beads
can be re-used for at least 5 times.
Based on our new rabbit monoclonal antibody technology (MonoRab^TM), this beads offers high binding
capacity, high purity, and withstand stringent washing steps, especially with buffers containing high
concentration of salt. The beads are resistant to up to 2 M NaCl, and to buffers with pH as low as 2.5.

GenScript MonoRab^TM Anti-DYKDDDDK Magnetic Beads are super paramagnetic beads with diameter of 70
μm, covalently coated with a rabbit monoclonal anti-DYKDDDDK antibody. The beads are supplied as 50%
slurry in TBS with 50% glycerol and 0.02% sodium azide. The MonoRab^TM Anti-DYKDDDDK Magnetic Beads
have a binding capacity of 1.5 mg DYKDDDDK-tagged protein (Size: 50KDa) per 1 ml settled beads. The beads
can be re-used for at least 5 times.
Based on our new rabbit monoclonal antibody technology (MonoRab^TM), this beads offers high binding
capacity, high purity, and withstand stringent washing steps, especially with buffers containing high
concentration of salt. The beads are resistant to up to 2 M NaCl, and to buffers with pH as low as 2.5.

Adeno-associated virus type 2 (AAV2) is a valuable vector for gene therapy. It is one member of the human parvovirus family which depends on co-infection with helper viruses such as adenovirus or herpes virus for efficient reproduction. AAV2 empty capsids are composed of three proteins, VP1, VP2 and VP3 with relative molecular masses of 87, 72 and 62 kDa, respectively.

Adeno-associated virus type 2 (AAV2) is a valuable vector for gene therapy. It is one member of the human parvovirus family which depends on co-infection with helper viruses such as adenovirus or herpes virus for efficient reproduction. AAV2 empty capsids are composed of three proteins, VP1, VP2 and VP3 with relative molecular masses of 87, 72 and 62 kDa, respectively.

Adeno-associated virus type 8 (AAV8) is a valuable vector for gene therapy. It is one member of the human parvovirus family which depends on co-infection with helper viruses such as adenovirus or herpes virus for efficient reproduction. AAV2 empty capsids are composed of three proteins, VP1, VP2 and VP3 with relative molecular masses of 87, 72 and 62 kDa, respectively.

Adeno-associated virus type 8 (AAV8) is a valuable vector for gene therapy. It is one member of the human parvovirus family which depends on co-infection with helper viruses such as adenovirus or herpes virus for efficient reproduction. AAV2 empty capsids are composed of three proteins, VP1, VP2 and VP3 with relative molecular masses of 87, 72 and 62 kDa, respectively.

The monoclonal antibody 24F5 react with the AAV capsid protein VP1. The antibody is suitable for application in western blot analysis due to their reactivity with linear epitopes present in the dentaured protein sequence of VP1 proteins

The monoclonal antibody 5G4 react with the three AAV capsid proteins VP1, VP2 and VP3. The antibody is suitable for application in western blot analysis due to their reactivity with linear epitopes present in the dentaured protein sequence of all three proteins.

The product is specific for Adalimumab. This antibody blocks Adalimumab binding with TNF-α (Z01001, TNF-α, Human) in ELISA. The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody GenScript, A01921-40, MonoRab™ Anti-Adalimumab Antibody (4E12), mAb, Rabbit.

The product is specific for Adalimumab. This antibody blocks Adalimumab binding with TNF-α (Z01001, TNF-α, Human) in ELISA. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01922-40, MonoRabTM Anti-Adalimumab Antibody (134D5), mAb, Rabbit.

The antibody is recommended as detection antibody in a pharmacokinetic (PK) bridging assay with captrue antibody GenScript, A01984-40, MonoRab Anti-Atezolizumab Antibody (55D8), mAb, Rabbit.

The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody GenScript, A01984-40, MonoRab Anti-Atezolizumab Antibody (55D8), mAb, Rabbit.

The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01985-40, MonoRab Anti-Atezolizumab Antibody (43H11), mAb, Rabbit.

The product is specific for Bevacizumab but can’t block vascular endothelial growth factor 165 (VEGF 165). The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01896-40, MonoRabTM Anti- Bevacizumab Antibody (46E3)[Biotin], mAb, Rabbit.

The product is specific for Bevacizumab. This antibody blocks Bevacizumab binding with VEGF165 (Z02689, VEGF165, Human). The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody GenScript, A01895-40, MonoRab Anti-Bevacizumab Antibody (30E1), mAb, Rabbit.

The product is specific for Bevacizumab. This antibody blocks Bevacizumab binding with VEGF165 (Z02689, VEGF165, Human). The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody GenScript, A01895-40, MonoRabTM Anti-Bevacizumab Antibody (30E1), mAb, Rabbit.

Camelid
VHH Antibody (also called single-domain antibody, sdAb or Nanobody by Ablynx)
is a peptide chain about 110 amino acids in length, containing one variable domain
of a heavy-chain antibody (a VHH fragment). Like a whole antibody, the camelid
VHH antibody is able to bind selectively to a specific antigen. This single-domain
antibody has a broad range of applications in biotechnical and therapeutic research
fields due to its small size, simple production and high affinity.
GenScript’s MonoRab™ Anti-Camelid VHH
Affinity Resin (Cat. No. L00905) is designed for purification of Camelid VHH
single domain antibody from commonly used protein expression systems such as bacteria,
yeast and mammalian cells. The VHH single domain antibody in cell lysate can specifically
bind to the Anti-Camelid VHH monoclonal antibody coupled to the resin. Nonspecific
binding reactions are eliminated by stringent washing steps, and the purified Camelid
VHH single domain antibody is eluted with a high recovery rate. Table
1 lists the main characteristics of GenScript’s MonoRab™ Anti-Camelid VHH
Affinity Resin.

 Table 1. Characteristics of Anti-Camelid VHH Affinity
Resin

Camelid
VHH Antibody (also called single-domain antibody, sdAb or Nanobody by Ablynx)
is a peptide chain about 110 amino acids in length, containing one variable domain
of a heavy-chain antibody (a VHH fragment). Like a whole antibody, the camelid
VHH antibody is able to bind selectively to a specific antigen. This single-domain
antibody has a broad range of applications in biotechnical and therapeutic research
fields due to its small size, simple production and high affinity.
GenScript’s MonoRab™ Anti-Camelid VHH
Affinity Resin (Cat. No. L00905) is designed for purification of Camelid VHH
single domain antibody from commonly used protein expression systems such as bacteria,
yeast and mammalian cells. The VHH single domain antibody in cell lysate can specifically
bind to the Anti-Camelid VHH monoclonal antibody coupled to the resin. Nonspecific
binding reactions are eliminated by stringent washing steps, and the purified Camelid
VHH single domain antibody is eluted with a high recovery rate. Table
1 lists the main characteristics of GenScript’s MonoRab™ Anti-Camelid VHH
Affinity Resin.

 Table 1. Characteristics of Anti-Camelid VHH Affinity
Resin

Camelid
VHH Antibody (also called single-domain antibody, sdAb or Nanobody by Ablynx)
is a peptide chain about 110 amino acids in length, containing one variable domain
of a heavy-chain antibody (a VHH fragment). Like a whole antibody, the camelid
VHH antibody is able to bind selectively to a specific antigen. This single-domain
antibody has a broad range of applications in biotechnical and therapeutic research
fields due to its small size, simple production and high affinity.
GenScript’s MonoRab™ Anti-Camelid VHH
Affinity Resin (Cat. No. L00905) is designed for purification of Camelid VHH
single domain antibody from commonly used protein expression systems such as bacteria,
yeast and mammalian cells. The VHH single domain antibody in cell lysate can specifically
bind to the Anti-Camelid VHH monoclonal antibody coupled to the resin. Nonspecific
binding reactions are eliminated by stringent washing steps, and the purified Camelid
VHH single domain antibody is eluted with a high recovery rate. Table
1 lists the main characteristics of GenScript’s MonoRab™ Anti-Camelid VHH
Affinity Resin.

 Table 1. Characteristics of Anti-Camelid VHH Affinity
Resin

Camelid
VHH Antibody (also called single-domain antibody, sdAb or Nanobody by Ablynx)
is a peptide chain about 110 amino acids in length, containing one variable domain
of a heavy-chain antibody (a VHH fragment). Like a whole antibody, the camelid
VHH antibody is able to bind selectively to a specific antigen. This single-domain
antibody has a broad range of applications in biotechnical and therapeutic research
fields due to its small size, simple production and high affinity.
GenScript’s MonoRab™ Anti-Camelid VHH
Affinity Resin (Cat. No. L00905) is designed for purification of Camelid VHH
single domain antibody from commonly used protein expression systems such as bacteria,
yeast and mammalian cells. The VHH single domain antibody in cell lysate can specifically
bind to the Anti-Camelid VHH monoclonal antibody coupled to the resin. Nonspecific
binding reactions are eliminated by stringent washing steps, and the purified Camelid
VHH single domain antibody is eluted with a high recovery rate. Table
1 lists the main characteristics of GenScript’s MonoRab™ Anti-Camelid VHH
Affinity Resin.

 Table 1. Characteristics of Anti-Camelid VHH Affinity
Resin

This product is specific for Certolizumab pegol.

This product is specific for Certolizumab pegol.

The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01992-40, MonoRab™ Anti-Cetuximab Antibody (90G3), mAb, Rabbit.

The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody GenScript, A01991-40, MonoRab™ Anti-Cetuximab Antibody (69H10), mAb, Rabbit.

The product is specific for Daratumumab.